Neuroinflammatory diseases, including Alzheimer’s disease and traumatic brain injury, have been linked to deposits of a tough protein known as fibrin, derived from the blood clotting factor fibrinogen. These mesh-like fibrin deposits occur outside blood vessels in the brain, contributing…
Read More
US NIH Halts Trial Testing COVID-19 Blood Plasma
(Reuters) — The U.S. National Institutes of Health (NIH) said on Tuesday it had halted a trial testing convalescent blood plasma in treatment of patients with mild to moderate COVID-19 symptoms. The NIH said an independent data monitoring board found…
Read More
COVID-19 survivors’ plasma might prevent worsening illness in older patients: study
Blood plasma from people recovering from COVID-19 could help prevent severe illness in older patients newly infected with the virus, a small new Argentinian study finds. The findings give new hope to the notion that so-called “convalescent plasma” might have…
Read More
Plasma helped severely ill patients but not life-threatening patients
Severely ill coronavirus patients treated with plasma from COVID-19 survivors recovered FIVE days faster – but the experimental treatment did not improve survival odds in life-threatening cases Convalescent plasma therapy is when the liquid portion of blood is taken from…
Read More
Using riboflavin, UV light reduces SARS-CoV-2 pathogens in plasma, whole blood
Scientists do not yet know if Severe Acute Respiratory Syndrome Coronavirus 2, or SARS-CoV-2—the virus that causes COVID-19—can be transmitted by blood transfusion. But given the unknowns around this new pathogen, researchers at Colorado State University used existing technologies to…
Read More
Plasma from recovered coronavirus patients DOES help those suffering
Coronavirus patients treated with plasma from people who recovered from the infection are nearly TWICE as likely to survive than those who didn’t get the experimental treatment, study finds Convalescent plasma therapy is when the liquid portion of blood is…
Read More
On the front lines: Jeffrey Henderson
Infectious diseases specialist Jeffrey Henderson, MD, PhD, an associate professor of medicine and of molecular microbiology at Washington University School of Medicine in St. Louis, explains plasma therapy and how it is being used in patients with COVID-19. Learn more…
Read More